COMMODORE CAPITAL LP 13D and 13G filings for Genocea Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:09 pm Purchase | 2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA | COMMODORE CAPITAL LP | 3,079,756 5.400% | 208,132 (+7.25%) | Filing |
| 2021-03-31 07:14 am Purchase | 2021-03-22 | 13G | Genocea Biosciences, Inc. GNCA | COMMODORE CAPITAL LP | 2,871,624 5.400% | 2,871,624 (New Position) | Filing |